Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Grace Breeding is an Israeli publicly traded agricultural biotechnology and AgClimateTech company developing biologically based alternatives to synthetic crop inputs. Its portfolio centers on bio-fertilizer, plant resilience, and crop-protection solutions intended to reduce synthetic fertilizer use, improve yields, and lower environmental impact. The company highlights Nitrogen Fixation Technology products such as Maoz and a plant-defense platform called Wide Defense System. Grace Breeding operates R&D in Rehovot, Israel, has additional facilities in Brazil, and appears focused on commercialization in Europe, Brazil, Israel, and the United States. Although it is a biotechnology company in the agricultural sense, it is not a human healthcare, pharma, or life sciences therapeutics company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Grace Breeding.